Enhancement of VDR-mediated transcription by phosphorylation: Correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex Journal Article


Authors: Barletta, F.; Freedman, L. P.; Christakos, S.
Article Title: Enhancement of VDR-mediated transcription by phosphorylation: Correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex
Abstract: When UMR-106 osteoblastic cells, LLCPK1 kidney cells, and VDR transfected COS-7 cells were transfected with the rat 24-hydroxylase [24(OH)ase] promoter (-1,367/+74) or the mouse osteopontin (OPN) promoter (-777/+79), we found that the response to 1,25dihydroxyvitamin D3 [1,25-(OH)2D3] could be significantly enhanced 2- to 5-fold by the protein phosphatase inhibitor, okadaic acid (OA). Enhancement of 1,25-(OH)2D3-induced transcription by OA was also observed using a synthetic reporter gene containing either the proximal 24(OH)ase vitamin D response element (VDRE) or the OPN VDRE, suggesting that the VDRE is sufficient to mediate this effect. OA also enhanced the 1,25-(OH)2D3-induced levels of 24(OH)ase and OPN mRNA in UMR osteoblastic cells. The effect of OA was not due to an up-regulation of VDR or to an increase in VDR-RXR interaction with the VDRE. To determine whether phosphorylation regulates VDR-mediated transcription by modulating interactions with protein partners, we examined the effect of phosphorylation on the protein-protein interaction between VDR and DRIP205, a subunit of the vitamin D receptor-interacting protein (DRIP) coactivator complex, using glutathione-S-transferase pull-down assays. Similar to the functional studies, OA treatment was consistently found to enhance the interaction of VDR with DRIP205 3- to 4-fold above the interaction observed in the presence of 1,25-(OH)2D3 alone. In addition, studies were done with the activation function-2 defective VDR mutant, L417S, which is unable to stimulate transcription in response to 1,25-(OH)2D3 or to interact with DRIP205. However, in the presence of OA, the mutant VDR was able to activate 24(OH)ase and OPN transcription and to recruit DRIP205, suggesting that OA treatment may result in a conformational change in the activation function-2 defective mutant that creates an active interaction surface with DRIP205. Taken together, these findings suggest that increased interaction between VDR and coactivators such as DRIP205 may be a major mechanism that couples extracellular signals to vitamin D action.
Keywords: signal transduction; controlled study; unclassified drug; mutation; nonhuman; animal cell; animals; mice; protein protein interaction; cell line; protein binding; genetic transcription; transcription, genetic; calcitriol; phosphorylation; animalia; transcription factors; gene expression regulation; enzyme inhibitors; rna, messenger; vitamin d; carrier proteins; glutathione transferase; reporter gene; rats; conformational transition; protein subunit; protein subunits; vitamin d receptor; swine; mutant; macromolecular substances; phosphoprotein phosphatase; cholecalciferol; receptor upregulation; osteopontin; okadaic acid; receptors, retinoic acid; promoter regions (genetics); cytochrome p-450 enzyme system; retinoid x receptors; receptors, calcitriol; priority journal; article; phosphoprotein phosphatase inhibitor; protein drip205; vitamin d binding protein; vitamin d responsive element; sialoglycoproteins; steroid hydroxylases; vitamin d response element
Journal Title: Molecular Endocrinology
Volume: 16
Issue: 2
ISSN: 0888-8809
Publisher: Endocrine Society  
Date Published: 2002-01-01
Start Page: 301
End Page: 314
Language: English
DOI: 10.1210/me.16.2.301
PUBMED: 11818502
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 14 November 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors